Table 4. Observed and expected prevalence (assuming the diseases occur independently, and based on the prevalence of each disease in the population) of disease triads with an observed prevalence higher than 10%.
DISEASE TRIADS | Prevalence / 100 | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CAN | CHD | AD | CVD | DM | HBP | HF | COPD | CKD | DD | AF | ASTH | HT | OP | HL | O | E | O/E | CI |
X | X | X | 24.19 | 24.42 | 0.99 | (0.90, 1.09) | ||||||||||||
X | X | X | 23.86 | 18.23 | 1.31 | (1.18, 1.45) | ||||||||||||
X | X | X | 20.07 | 17.13 | 1.17 | (1.05, 1.31) | ||||||||||||
X | X | X | 19.36 | 18.66 | 1.04 | (0.93, 1.16) | ||||||||||||
X | X | X | 16.98 | 13.46 | 1.26 | (1.11, 1.43) | ||||||||||||
X | X | X | 16.39 | 14.91 | 1.10 | (0.97, 1.24) | ||||||||||||
X | X | X | 15.79 | 14.42 | 1.10 | (0.96, 1.24) | ||||||||||||
X | X | X | 13.79 | 5.80 | 2.38 | (1.99, 2.84) | ||||||||||||
X | X | X | 12.86 | 12.86 | 1.00 | (0.87, 1.15) | ||||||||||||
X | X | X | 12.00 | 12.08 | 0.99 | (0.86, 1.15) | ||||||||||||
X | X | X | 11.71 | 9.12 | 1.28 | (1.10, 1.50) | ||||||||||||
X | X | X | 11.04 | 10.14 | 1.09 | (0.93, 1.27) | ||||||||||||
X | X | X | 11.00 | 9.20 | 1.20 | (1.02, 1.40) | ||||||||||||
X | X | X | 10.74 | 10.52 | 1.02 | (0.87, 1.19) | ||||||||||||
X | X | X | 10.59 | 7.38 | 1.43 | (1.21, 1.71) | ||||||||||||
X | X | X | 10.52 | 9.83 | 1.07 | (0.91, 1.25) |
CAN = cancer; CHD = coronary heart disease; AD = Alzheimer’s disease; CVD = cerebrovascular disease; DM = diabetes mellitus; HBP = high blood pressure; HF = heart failure; COPD = chronic obstructive pulmonary disease; CKD = chronic kidney disease; DD = depressive disorder; AF = atrial fibrillation; ASTH = asthma; OP = osteoporosis; HT = hypothyroidism; HL = hyperlipidemia.